Glucose Com Cloreto De Sodio Paracélsia

Glucose Com Cloreto De Sodio Paracélsia is an injectable solution that combines sodium chloride and glucose in a sterile aqueous formulation for intravenous use. The product is supplied as a solution for injection, intended for administration through a vein, and originates from the European Union market. It is used where fluid, electrolyte, and energy replacement are required in clinical settings.

Glucose Com Cloreto De Sodio Paracélsia is employed in a variety of clinical situations that require intravenous fluid and electrolyte management. It is commonly used for: - Restoring extracellular fluid volume in patients with dehydration or blood loss. - Providing sodium chloride to correct hyponatremia or maintain electrolyte balance. - Supplying glucose as an energy source during fasting, surgery, or critical illness. - Managing mild to moderate hypoglycemia when oral glucose is not feasible. - Supporting maintenance fluids for patients unable to tolerate oral intake.

Side effects of Glucose Com Cloreto De Sodio Paracélsia are generally related to the intravenous administration of fluids and electrolytes. They may vary in frequency and severity.

Common: - Local irritation or pain at the injection site. - Mild nausea or vomiting. - Transient hyperglycemia. - Mild electrolyte imbalance (e.g., hypernatremia). - Fluid overload in patients with compromised cardiac function.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Significant electrolyte disturbances (e.g., severe hypernatremia or hyponatremia). - Anaphylactic or severe allergic reaction. - Pulmonary edema from excessive fluid administration.

When using Glucose Com Cloreto De Sodio Paracélsia, clinicians should consider several safety measures. Important precautions include: - Assessing the patient’s fluid status and cardiac function before administration. - Monitoring blood glucose levels regularly during infusion. - Checking serum electrolytes, especially sodium, before and after therapy. - Adjusting infusion rates in patients with renal impairment or heart failure. - Using aseptic technique to prevent contamination. - Ensuring compatibility with other intravenous medications before co‑administration.

Glucose Com Cloreto De Sodio Paracélsia may interact with other drugs or solutions administered intravenously. Awareness of potential interactions helps avoid adverse outcomes.

Avoid: - Co‑infusion with hypertonic saline solutions that could exacerbate hypernatremia. - Simultaneous administration with medications that require a specific pH or osmolarity, such as certain antibiotics.

Use with caution: - Concurrent use of insulin or other hypoglycemic agents, which may increase the risk of hypoglycemia. - Diuretics, which can alter electrolyte balance. - Vasoactive drugs, where rapid fluid shifts may affect hemodynamics. - Blood products, to prevent dilutional coagulopathy.